These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 36583462)

  • 21. Comparative Assessment of Off-label and Unlicensed Drug Prescriptions in Children: FDA Versus ANSM Guidelines.
    Berdkan S; Rabbaa L; Hajj A; Eid B; Jabbour H; Osta NE; Karam L; Khabbaz LR
    Clin Ther; 2016 Aug; 38(8):1833-44. PubMed ID: 27392716
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Off-label use of psychotropic drugs in a Swiss paediatric service: similar results from two different cohort studies.
    Feka A; Di Paolo ER; Pauchard JY; Mariguesa A; Gehri M; Sadeghipour F
    Swiss Med Wkly; 2022 Jan; 152():w30124. PubMed ID: 35147399
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Off-Label Use of Drugs and Adverse Drug Reactions in Pediatric Units: A Prospective, Multicenter Study.
    Pratico AD; Longo L; Mansueto S; Gozzo L; Barberi I; Tiralongo V; Salvo V; Falsaperla R; Vitaliti G; La Rosa M; Leonardi S; Rotondo A; Avola N; Sgarlata D; Damiano A; Tirantello M; Anzelmo G; Cipolla D; Rizzo A; Russo A; Ruggieri M; Salomone S; Drago F
    Curr Drug Saf; 2018; 13(3):200-207. PubMed ID: 29921210
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Safety of Off-Label Pharmacological Treatment in Pediatric Neuropsychiatric Disorders: A Global Perspective From an Observational Study at an Italian Third Level Children's Hospital.
    Giurin MS; Trojniak MP; Arbo A; Carrozzi M; Abbracciavento G; Monasta L; Zanus C
    Front Pharmacol; 2022; 13():837692. PubMed ID: 35496268
    [No Abstract]   [Full Text] [Related]  

  • 25. Off-label antibiotic use in a specialized children care hospital in Punjab, Pakistan: Findings and implications.
    Hafeez M; Saleem Z; Bukhari NA; Hussain K; Shamim R; Hussain A; Bukhari NI
    J Infect Dev Ctries; 2020 May; 14(5):540-544. PubMed ID: 32525842
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecularly targeted therapy based on tumour molecular profiling versus conventional therapy for advanced cancer (SHIVA): a multicentre, open-label, proof-of-concept, randomised, controlled phase 2 trial.
    Le Tourneau C; Delord JP; Gonçalves A; Gavoille C; Dubot C; Isambert N; Campone M; Trédan O; Massiani MA; Mauborgne C; Armanet S; Servant N; Bièche I; Bernard V; Gentien D; Jezequel P; Attignon V; Boyault S; Vincent-Salomon A; Servois V; Sablin MP; Kamal M; Paoletti X;
    Lancet Oncol; 2015 Oct; 16(13):1324-34. PubMed ID: 26342236
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Compassionate drug uses in Italy. Analysis of regional and local diffusion.
    Pilunni D; Navarra P
    Ann Ist Super Sanita; 2023; 59(1):43-50. PubMed ID: 36974704
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Off-label prescribing in pediatric outpatients.
    Palmaro A; Bissuel R; Renaud N; Durrieu G; Escourrou B; Oustric S; Montastruc JL; Lapeyre-Mestre M
    Pediatrics; 2015 Jan; 135(1):49-58. PubMed ID: 25511119
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adverse drug reactions associated with off-label use of ketorolac, with particular focus on elderly patients. An analysis of the Italian pharmacovigilance database and a population based study.
    Viola E; Trifirò G; Ingrasciotta Y; Sottosanti L; Tari M; Giorgianni F; Moretti U; Leone R
    Expert Opin Drug Saf; 2016 Dec; 15(sup2):61-67. PubMed ID: 27875919
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prescription Pattern Monitoring and Off-label Use of Medicines in the Pediatric Department at Tertiary Care Teaching Hospital.
    Pandey S; Yadav CK; Ghimire P; Shrestha AC
    Kathmandu Univ Med J (KUMJ); 2020 Oct.-Dec.; 18(72):367-371. PubMed ID: 34165093
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Access to innovative therapies in pediatric oncology: Report of the nationwide experience in Canada.
    Judd S; Revon-Riviere G; Grover SA; Deyell RJ; Vanan MI; Lewis VA; Pecheux L; Zorzi AP; Goudie C; Santiago R; Tran TH; Abbott LS; Brossard J; Moorehead P; Alvi S; Portwine C; Denburg A; Whitlock JA; Cohen-Gogo S; Morgenstern DA
    Cancer Med; 2024 Feb; 13(3):e7033. PubMed ID: 38400668
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In-label and off-label use of respiratory drugs in the Italian paediatric population.
    Baiardi P; Ceci A; Felisi M; Cantarutti L; Girotto S; Sturkenboom M; Baraldi E
    Acta Paediatr; 2010 Apr; 99(4):544-9. PubMed ID: 20105140
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of unlicensed and off-label antiepileptic drugs prescribed to children: Brazilian Regulatory Agency versus FDA.
    Borges AP; Campos MS; Pereira LR
    Int J Clin Pharm; 2013 Jun; 35(3):425-31. PubMed ID: 23430533
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of off-label nephrology-related drugs in hospitalized pediatric patients: a retrospective study.
    Yasinta M; Che RC; Hu CY; Du XH; Ding GX; Huang SM; Chen Y; Zhang AH
    World J Pediatr; 2016 May; 12(2):236-42. PubMed ID: 26684307
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Outcomes of off-label drug uses in hospitals: a multicentric prospective study.
    Danés I; Agustí A; Vallano A; Alerany C; Martínez J; Bosch JA; Ferrer A; Gratacós L; Pérez A; Olmo M; Marron SM; Valderrama A; Bonafont X
    Eur J Clin Pharmacol; 2014 Nov; 70(11):1385-93. PubMed ID: 25196202
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Off-label drugs in childhood psoriasis].
    Mahé E; Corgibet F; Maccari F; Hadj-Rabia S; Phan C; Ruer-Mulard M; Boralévi F; Barbarot S; Bursztejn AC; Lahfa M; Severino-Freire M; Aubin F; Barthélémy H; Amy de la Bretêque M; Beauchet A; ; ; ;
    Ann Dermatol Venereol; 2020; 147(6-7):429-438. PubMed ID: 32299624
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Off-label and unlicensed drug use in a pediatric intensive care unit of a tertiary care Spanish hospital. A descriptive study.
    Camacho Arroyo MT; Rivas Paterna AB; Meneses Monroy A; Cabrera García L; Blázquez González P; Mancebo Salas N; Rodríguez Leal L; Vargas Castrillón E
    Arch Argent Pediatr; 2023 Feb; 121(1):e202102550. PubMed ID: 36194689
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of Unlicensed and Off-Label Use of Antipsychotics Prescribed to Child and Adolescent Psychiatric Outpatients for Treatment of Mental and Behavioral Disorders with Different Guidelines: The China Food and Drug Administration Versus the FDA.
    Zhu X; Hu J; Sun B; Deng S; Wen Y; Chen W; Qiu C; Shang D; Zhang M
    J Child Adolesc Psychopharmacol; 2018 Apr; 28(3):216-224. PubMed ID: 29336603
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Off-label indications for antidepressants in primary care: descriptive study of prescriptions from an indication based electronic prescribing system.
    Wong J; Motulsky A; Abrahamowicz M; Eguale T; Buckeridge DL; Tamblyn R
    BMJ; 2017 Feb; 356():j603. PubMed ID: 28228380
    [No Abstract]   [Full Text] [Related]  

  • 40. Prescribing for off-label use and unauthorized medicines in three paediatric wards in Finland, the status before and after the European Union Paediatric Regulation.
    Lindell-Osuagwu L; Hakkarainen M; Sepponen K; Vainio K; Naaranlahti T; Kokki H
    J Clin Pharm Ther; 2014 Apr; 39(2):144-53. PubMed ID: 24329556
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.